Related Experiment Video
Updated: May 2, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Comparing the efficacy of technology-enabled treatments for insomnia: study protocol for a randomized controlled
Hannah Scott1, Madelaine Green1, Kerri Jones1
1Flinders Health and Medical Research Institute: Sleep Health, Flinders University, Adelaide, South Australia, Australia.
This study compares digital insomnia therapies: Intensive Sleep Retraining with THIM, Sleep Healthy Using the Internet (SHUTi), and both, against a waitlist. It aims to find the most effective and cost-beneficial treatment for chronic insomnia.
Area of Science:
- Sleep Medicine
- Digital Health
- Behavioral Science
Background:
- Chronic insomnia affects many, yet few receive recommended Cognitive Behavioural Therapy for Insomnia (CBT-I).
- Digital therapies offer scalable solutions, but comparative efficacy data is lacking.
- Identifying optimal technology-enabled treatments is crucial for improving patient care.
Purpose of the Study:
- To compare the efficacy and cost-benefits of Intensive Sleep Retraining (THIM), Sleep Healthy Using the Internet (SHUTi), and a combination (THIM then SHUTi) against a waitlist control.
- To evaluate these digital interventions for chronic insomnia disorder.
Main Methods:
- A 4x3 randomized controlled trial comparing four treatment arms (+/- THIM, +/- SHUTi) across three time points (pre-treatment, post-treatment, 2-month follow-up).
- Participants with Chronic Insomnia Disorder were randomized.
- Outcomes assessed via daily/weekly self-reports and objective sleep trackers; primary outcome: total wake time.
Main Results:
- The study is designed to analyze the interaction between treatment group and time on total wake time using repeated measures ANOVA.
- A reduction of ≥30 minutes in total wake time is considered clinically meaningful.
- Results will provide comparative data on the effectiveness of different digital insomnia treatments.
Conclusions:
- This research will be the first to directly compare the efficacy of two distinct technology-enabled insomnia treatments.
- Findings will inform clinical practice and public health policy on digital health interventions for insomnia.
- The study will guide the use of publicly and privately funded technology-enabled insomnia solutions.
More Related Videos
Related Concept Videos
Blind Procedures
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Insomnia
Multiple factors contribute...

